Ankylosis - 220 Studies Found
| Not yet recruiting |
: Combined Treatment With TNF Inhibitor and Pamidronate in AS Patients: Effect on the Radiographic Progression : Ankylosing Spondylitis : 2014-12-01 :
|
| Completed |
: To Investigate Genetic Factors Associated With the Response to Anti-TNF Therapy in Patients With Early AS : Ankylosing Spondylitis : 2014-12-04 |
| Enrolling by invitation |
: The Effect of Acupuncture Protocol Involving in Weizhong (BL4) and Huantiao (GB30) Points in Treating Ankylosing Spondylitis : Ankylosing Spondylitis : 2014-10-03 :
|
| Enrolling by invitation |
: The Effect of Acupotome in Treating Ankylosing Spondylitis : Ankylosing Spondylitis : 2014-10-02 :
|
| Recruiting |
: Defining Remission With Etanercept in AS in Real Life Clinical Practice : Ankylosing Spondylitis : 2014-07-23 : Drug: etanercept etanercept 1 x 50 mg/week or 2 x 25mg/week |
| Completed |
: A Study of Golimumab in Participants With Active Ankylosing Spondylitis : Ankylosing Spondylitis : 2014-07-08 :
|
| Completed |
: Evaluation of Efficacy and Safety of Meloxicam Suppository (15mg Daily) and Tablet (15 mg Daily) Compared to Indomethacin Suppository (50 mg Daily) in Patients With Ankylosing Spondylitis : Spondylitis, Ankylosing : 2014-07-04 :
|
| Active, not recruiting |
: Extension in AS: Sustainability of Benefits, Safety and Tolerability : Spondylitis, Ankylosing : 2013-05-23 : Biological: Secukinumab Eligible patients having completed the core study continue in the extension stud |
| Completed |
: Assial - Anti Tnf Treatment in Ankylosing Spondylitis: an Observational Cohort Study in Italy : Ankylosing Spondylitis : 2013-05-14 : Other: no intervention in real life of drug,dosage,frequency and duration |
| Completed |
: Remicade in the Treatment of Patients With Active Ankylosing Spondylitis : Ankylosing Spondylitis : 2013-05-06 : Drug: Infliximab 5 mg/kg every 6 weeks during the first year and 3 mg/kg every 8 weeks during the second |